JSI-124 treatment (Fig. 1D) confirmed the contact-dependency of STAT3 activation, as we have previously demonstrated that this JAK2 inhibitor selectively blocks contact-dependent STAT3 activation but not that induced by soluble factors, such as IL-10 or tumor cells conditioned media [9]. Here, JAK2 is linked to neoplasm.